Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
TOLTRAZURIL
Dopharma Research B.V.
QP51AJ01
TOLTRAZURIL
25 Mg/Ml
Oral Solution
POM
Fowl - Chicken
Toltrazuril
Coccidiostats
Authorised
2012-05-25
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Dozuril 25 mg/ml solution for use in drinking water for chickens. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for use in drinking water. Clear colourless to brown solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens (pullets and breeders). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of coccidiosis in pullets and broiler breeders. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Good hygiene can reduce the risk of coccidiosis. It is therefore recommended that any deficiencies in husbandry should be addressed in addition to treatment. Poultry houses should be kept clean and dry. It is recommended that all individuals in the group are treated. For best results, treatment should be initiated before the clinical signs of disease have spread throughout the whole group. Each 1 ml contains: Active substance: Toltrazuril 25.0 mg For a full list of excipients, see section 6.1 IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 27/02/2014_ _CRN 7015892_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS As with all anticoccidials, prolonged use may result in the development of resistant strains. II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Avoid skin and eye contact with the product. Wear personal protective clothing, including synthetic rubber gloves when handling the product. Wash any splashes from skin or eyes immediately with water. Wash hands and any exposed skin after use. Do not eat, drink or smoke whilst using the product. III) OTHER PRECAUTIO Read the complete document